Concepedia

L Sekar

LS

8

Publications

490

Citations

8

H-Index

2002

Active since

Affiliations

National Institute of Research in Tuberculosis(Current)

Government Hospital of Thoracic Medicine

Indian Council of Medical Research

Government Rajaji Hospital

L Sekar is an author at National Institute of Research in Tuberculosis specializing in drug resistance, tuberculosis, and medicine.

ORCID

Top concepts

Publications per year

2002–2020

8

Publications

8

Decreased Bioavailability of Rifampin and Other Antituberculosis Drugs in Patients with Advanced Human Immunodeficiency Virus Disease

Prema Gurumurthy, Geetha Ramachandran, A. K. Hemanth Kumar et al. · Antimicrobial Agents and Chemotherapy · 2004 · 153 citations · Full text

Malabsorption of Rifampin and Isoniazid in HIV‐Infected Patients With and Without Tuberculosis

Prema Gurumurthy, Geetha Ramachandran, A. K. Hemanth Kumar et al. · Clinical Infectious Diseases · 2004 · 114 citations · Full text

, , +8

Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children

Geetha Ramachandran, A K Hemanth Kumar, Perumal Kannabiran Bhavani et al. · The International Journal of Tuberculosis and Lung Disease · 2013 · 90 citations

Private pharmacies in tuberculosis control--a neglected link.

R. Rajeswari, Ravikumar Balasubramanian, M S C Bose et al. · PubMed · 2002 · 46 citations

, , +14

Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy

Gopalan Narendran, Pradeep A. Menon, P. Venkatesan et al. · Clinical Infectious Diseases · 2014 · 36 citations · Full text

Rows per page

1–5 of 8